Meral Beksac, MD, Ankara University, Ankara, Turkey, sheds light on the management of multiple myeloma (MM) patients during the COVID-19 pandemic. Dr Beksac discusses some of the most challenging cases and reveals that patients should continue their therapy. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).